News
PYPD
3.545
+3.35%
0.115
Weekly Report: what happened at PYPD last week (1111-1115)?
Weekly Report · 5d ago
PolyPid (PYPD) Gets a Hold from Barclays
TipRanks · 5d ago
Positive Indicators and Financial Stability Support Roy Buchanan’s Optimistic Outlook on PolyPid’s Stock
TipRanks · 11/14 15:55
PolyPid Reports Q3 Results Amid SHIELD II Trial Progress
TipRanks · 11/14 04:05
PolyPid reports 9M results
Seeking Alpha · 11/13 15:52
PolyPid Announces SHIELD II Trial Progress and Financials
TipRanks · 11/13 12:32
PolyPid sees runway into 1Q25
TipRanks · 11/13 12:25
PolyPid Q3 2024 GAAP EPS $(1.22) Misses $(0.96) Estimate; Cash On Hand $9.5M
Benzinga · 11/13 12:07
Earnings Scheduled For November 13, 2024
Benzinga · 11/13 08:32
PolyPid (PYPD) Receives a Buy from Craig-Hallum
TipRanks · 11/11 13:36
Weekly Report: what happened at PYPD last week (1104-1108)?
Weekly Report · 11/11 09:44
PolyPid Announces $8.25 Million Share Sale Plan
TipRanks · 11/08 21:28
Craig-Hallum Initiates Coverage of PolyPid (PYPD) with Buy Recommendation
NASDAQ · 11/05 01:21
PolyPid Initiated at Buy by Craig-Hallum
Dow Jones · 11/04 17:29
PolyPid Price Target Announced at $10.00/Share by Craig-Hallum
Dow Jones · 11/04 17:29
Craig-Hallum Initiates Coverage On PolyPid with Buy Rating, Announces Price Target of $10
Benzinga · 11/04 17:18
Craig-Hallum bullish on PolyPid, initiates with a Buy
TipRanks · 11/04 13:55
PolyPid initiated with a Buy at Craig-Hallum
TipRanks · 11/04 12:25
Weekly Report: what happened at PYPD last week (1028-1101)?
Weekly Report · 11/04 09:43
PolyPid to Report Third Quarter 2024 Financial Results and Operational Highlights on November 13, 2024
Barchart · 10/30 07:00
More
Webull provides a variety of real-time PYPD stock news. You can receive the latest news about Polypid Ltd. through multiple platforms. This information may help you make smarter investment decisions.
About PYPD
Polypid Ltd is a biopharmaceutical company at the clinical stage, based in Israel . The company focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.